scholarly journals Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virological response

Hepatology ◽  
2010 ◽  
Vol 52 (4) ◽  
pp. 1519-1520
Author(s):  
Brian L. Pearlman ◽  
Carole Ehleben
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Trial ◽  
Virological Response ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Peginterferon Alfa

scholarly journals Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response

Hepatology ◽  
2010 ◽  
Vol 52 (4) ◽  
pp. 1201-1207 ◽  
Author(s):  
Maria Buti ◽  
Yoav Lurie ◽  
Natalia G. Zakharova ◽  
Natalia P. Blokhina ◽  
Andrzej Horban ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Randomized Trial ◽  
Virologic Response ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Peginterferon Alfa

Impact of Ribavirin Dose Reductions in Hepatitis C Virus Genotype 1 Patients Completing Peginterferon Alfa-2a/Ribavirin Treatment

2007 ◽  
Vol 5 (1) ◽  
pp. 124-129 ◽  
Author(s):  
K. Rajender Reddy ◽  
Mitchell L. Shiffman ◽  
Timothy R. Morgan ◽  
Stefan Zeuzem ◽  
Stephanos Hadziyannis ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Genotype 1 ◽  
Virus Genotype ◽  
Peginterferon Alfa ◽  
Dose Reductions
Sign in / Sign up

Export Citation Format

Share Document